Identifying biomarkers to improve treatment outcomes for rheumatoid arthritis patients – Dr Darren Plant speaks to Arthritis Digest Posted: Thursday, March 2, 2023 For Arthritis Digest magazine, Dr Darren Plant explains how the future will see us identify biomarkers to improve rheumatoid arthritis treatment outcomes. Read More
Inflammatory arthritis diagnosis from past to present – Professor Anne Barton speaks to Arthritis Digest Posted: Thursday, January 26, 2023 Speaking to Arthritis Digest magazine, Professor Anne Barton explains how a diagnosis of inflammatory arthritis is life changing, but is no longer a life sentence. Read More
Interrupting the treatment of vulnerable people on immune-suppressing medicines, doubles their antibody response to COVID-19 booster vaccination Posted: Monday, July 11, 2022 A major clinical trial supported by Manchester BRC researchers has found that by interrupting the treatment of vulnerable people on long-term immune supressing medicines for two weeks after a COVID-19 booster vaccination, their antibody response to the jab is doubled. Read More
Taking charge of arthritis – Dr James Bluett speaks to Arthritis Digest Posted: Friday, May 13, 2022 BRC Musculoskeletal researcher Dr James Bluett talks to Arthritis Digest magazine about how new tests will support patients with rheumatoid arthritis to regain control of their health. Read More
Manchester BRC musculoskeletal researchers publish ‘ground-breaking’ national guidelines for myositis Posted: Wednesday, May 11, 2022 Researchers from Manchester BRC’s Musculoskeletal (MSK) Theme have published the first guidelines on the care and treatment of patients with the rare autoimmune condition, myositis. Read More
Myositis and remote patient monitoring – Dr Alexander Oldroyd speaks to Arthritis Digest Posted: Monday, March 14, 2022 Continuing regular contributions from our BRC Musculoskeletal (MSK) theme researchers, Dr Alexander Oldroyd speaks to Arthritis Digest magazine about how technology could potentially help predict flares in patients with the autoimmune condition, myositis. Read More
Manchester BRC researchers receive prestigious national appointments Posted: Monday, March 14, 2022 Three researchers from Manchester Biomedical Research Centre (BRC) have been appointed Senior Investigators by the National Institute for Health Research (NIHR). Read More
UK collaboration sees NIHR IMID BioResource pass major recruitment milestone Posted: Tuesday, February 15, 2022 The NIHR Immune Mediated Inflammatory Disease (IMID) BioResource recently hit a major recruitment milestone of 2000 volunteers, thanks to the collaborative effort of centres across England. Read More